CD4 and Parkinson disease: We finally investigated whether the velocity and directionality of the PD-derived CD4 + cells were affected by disease stage, disease duration or levodopa medication, but found no significant correlations (Supplementary Fig. 1, Spearman’s rho p > 0.05).